Key Technologies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies
Continue
Learn More
Close
☰
Search
×
Home
About Us
Add Company
Advertise with us
Contact us
Events
Suplpiers
News
Clinical Trials
Drug Discovery
Packaging & Supply Chain
Production & Sales
Regulation
Advertise With Us
Advertise on our extensive network of industry websites and newsletters.
Get the PBR newsletter
Sign up to our free email to get all the latest PBR news.
Home
Drug Discovery
Drug Discovery
Research & Development
Pre-clinical Studies
Research & Development
Bayer partners with NextRNA to develop lncRNA-targeting cancer therapies
Drug Discovery
Research & Development
Oncology
Aarvik announces ADC option exercise by collaboration partner ArriVent
Research & Development
Clinical Trials
Clinical Trials
Patient Enrollment
Human Trials
Patient Enrollment
US FDA approves Avacta Group’s IND application for AVA6000
Clinical Trials
Patient Enrollment
AM-Pharma enrols first patients in Covid-19 phase III trial
Clinical Trials
Patient Enrollment
Regulation
Regulation
Drug Filing
Approvals
Rejections
Marketing Authorisation
Patents
Lawsuits
Drug Filing
FDA grants priority review for Bavarian Nordic’s chikungunya vaccine BLA
Research & Development
Regulation
Drug Filing
FDA accepts Exelixis’ cabozantinib sNDA for neuroendocrine tumours
Regulation
Drug Filing
Production & Sales
Production & Sales
Manufacturing
Launches
Recalls
Marketing & Sales
Manufacturing
Merck launches GMP-compliant cell culture media line in China
Drug Discovery
Manufacturing
Rosemont acquires Pharma-Data to enhance global product development
Manufacturing
Packaging & Supply Chain
Packaging & Supply Chain
Packaging
Cold Chain Distribution
Storage
Packaging
Gerresheimer
Packaging
PCI Pharma announces bottling line expansion at Rockford site
Packaging & Supply Chain
Packaging
Suppliers
Suppliers
A-Z Suppliers
Products & Services
Videos
White Papers
No data found
Events
Register
Log In
SAI Life Sciences
FOLLOW
More info about
SAI Life Sciences
Key Technologies
SAI Life Sciences
Share
SEND TO A COLLEAGUE
High Potency 0.1 and 1.0-10 µg/m3 (OEL 4-5)
Enantioselective Hydrogenation
Cryogenic Reactions (-80°C)
Expertise in Salt, Polymorph Screening & Crystallization
Prostaglandins
Vitamin – D Analogues
Saccharide Chemistry for Oligo Building Blocks
Solution phase peptides up to 10-mer
Micronization
Particle Size Analyzer
Lyophilizer (20 L/day of water evaporation in Kilo-scale)
Preparative and commercial Scale Chromatography – For handling most commercial scale separation needs (1-25 kg)
Expertise in ion-exchange, size exclusion, ion interaction chromatography
Supercritical Fluid Chromatography (Both analytical and Preparative)
Formulations:
Extended release product – HPMC matrix tablet, Zein Coating, pellets/Beads
Combination Product – Combination of 2IR Drugs or IR + ER Drugs
Orally Dissolving Tablet (ODT) – Taste Mask, Delayed Release
Liposome Development – Targeted Tissue Delivery, Gradient Loading Technique
Lyophilization – Thermo-labile compounds, Cytotoxic compounds
Quick Contact Key Technologies
SAI Life Sciences
FOLLOW